Evidence map›Paper›PMID 36877445›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line.

Wendy Malespín-Bendaña, Rui M Ferreira, Marta T Pinto, Ceu Figueiredo, Warner Alpízar-Alpízar, Clas Une, Lucía Figueroa-Protti, Vanessa Ramírez

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Journal of gastrointestinal oncology · 2026
    Article
  2. Helicobacter pylori outer membrane vesicle-induced hsa-miR-302a-3p and hsa-miR-184 promote the occurrence and development of gastric cancer.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Wendy Malespín-BendañaInstitute of Health Research (INISA), University of Costa Rica, 11501-2060, San José, Costa Rica. wendy.malespin@ucr.ac.cr.ORCID http://orcid.org/0000-0002-1466-4815
Rui M FerreiraInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Marta T PintoInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Ceu FigueiredoInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Warner Alpízar-AlpízarCenter for Research On Microscopic Structures (CIEMic), University of Costa Rica, San José, Costa Rica.
Clas UneInstitute of Health Research (INISA), University of Costa Rica, 11501-2060, San José, Costa Rica.
Lucía Figueroa-ProttiCenter for Research On Microscopic Structures (CIEMic), University of Costa Rica, San José, Costa Rica.
Vanessa RamírezInstitute of Health Research (INISA), University of Costa Rica, 11501-2060, San José, Costa Rica.
Universidad de Costa Rica · CRUniversidade do Porto · PT

Funding

European Regional Development Fund NORTE-07-0124-FEDER- 000022FCT Scientific Employment Stimulus-Individual Call CEECIND/01854/2017
6 · The paper itself

Abstract

Helicobacter pylori colonizes the stomach and induces an inflammatory response that can develop into gastric pathologies including cancer. The infection can alter the gastric vasculature by the deregulation of angiogenic factors and microRNAs. In this study, we investigate the expression level of pro-angiogenic genes (ANGPT2, ANGPT1, receptor TEK), and microRNAs (miR-135a, miR-200a, miR-203a) predicted to regulate those genes, using H. pylori co-cultures with gastric cancer cell lines. In vitro infections of different gastric cancer cell lines with H. pylori strains were performed, and the expression of ANGPT1, ANGPT2, and TEK genes, and miR-135a, miR-200a, and miR-203a, was quantified after 24 h of infection (h.p.i.). We performed a time course experiment of H. pylori 26695 infections in AGS cells at 6 different time points (3, 6, 12, 28, 24, and 36 h.p.i.). The angiogenic response induced by supernatants of non-infected and infected cells at 24 h.p.i. was evaluated in vivo, using the chicken chorioallantoic membrane (CAM) assay. In response to infection, ANGPT2 mRNA was upregulated at 24 h.p.i, and miR-203a was downregulated in AGS cells co-cultured with different H. pylori strains. The time course of H. pylori 26695 infection in AGS cells showed a gradual decrease of miR-203a expression concomitant with an increase of ANGPT2 mRNA and protein expression. Expression of ANGPT1 and TEK mRNA or protein could not be detected in any of the infected or non-infected cells. CAM assays showed that the supernatants of AGS-infected cells with 26695 strain induced a significantly higher angiogenic and inflammatory response. Our results suggest that H. pylori could contribute to the process of carcinogenesis by downregulating miR-203a, which further promotes angiogenesis in gastric mucosa by increasing ANGPT2 expression. Further investigation is needed to elucidate the underlying molecular mechanisms.

Indexed as

Helicobacter InfectionsHelicobacter pyloriMicroRNAsStomach NeoplasmsAngiopoietin-1Angiopoietin-2Cell LineCell Line, TumorGastric MucosaHumansRNA, MessengerAngiopoietin-1Angiopoietin-2ANGPT1 protein, humanANGPT2 protein, humanMicroRNAsMIRN203 microRNA, humanRNA, MessengerAngiogenesisANGPT1ANGPT2Helicobacter pylorimiR-203a

Identifiers

PMID36877445
PMCPMC10235401
OpenAlexW4323294772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.